Business
Avacta to Host Therapeutics Division Science Day
Avacta to Host Therapeutics Division Science Day.
About this update from Avacta Group Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n \n 19th December 2022\n \n \n \n Avacta Group plc\n \n \n \n \n \n \n \n \n (\"Avacta\" or \"the Group\" or \"the Company\")\n \n \n \n \n \n \n \n \n Avacta to Host Therapeutics Division Science Day on 23rd February 2023\n \n \n \n \n \n \n \n \n \n Science Day to include presentation of the data emerging from the phase 1a clinical trial of AVA6000\n \n \n \n \n \n \n \n \n Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, will host a\n Science Day for City analysts and fund managers on 23rd February 2023 to discuss recent progress within the Company's Therapeutics Division and hear from selected key opinion leaders in the field of oncology.\n \n \n \n \n \n The event will include an update on the ongoing preclinical programmes as well as on progress in the ALS-6000-101 phase 1a clinical trial of AVA6000, Avacta's lead pre|CISIONTM tumour targeted chemotherapeutic, a modified form of the chemotherapy doxorubicin.\n \n \n \n \n \n The Company will update the Market on progress in this study in early January 2023, in advance of the Science Day.\n \n \n \n \n \n A recording of the presentations will be available after the event on Avacta's website\n \n \n www.avacta.com\n \n \n .\n \n \n \n \n \n \n \n \n -Ends-\n \n \n \n \n \n \n \n \n For further information from Avacta Group plc, please contact:\n \n \n \n \n \n \n \n \n \n \n \n \n \n Avacta Group plc\n \n \n \n Alastair Smith, Chief Executive Officer\n \n \n Tony Gardiner, Chief Financial Officer\n \n \n Michael Vinegrad, Group Communications Director\n \n \n \n \n \n \n \n Tel: +44 (0) 1904 21 7070\n \n \n \n www.avacta.com\n \n \n \n \n \n \n \n Stifel Nicolaus Europe Limited\n \n (Nomad and Broker)\n \n \n \n Nicholas Moore / Nick Adams / Samira Essebiyea / Nick Harland / Dhiren Suares / William Palmer-Brown\n \n \n \n \n \n \n \n Tel: +44 (0) 207 710 7600\n \n \n \n www.stifel.com\n \n \n \n \n \n \n \n FTI Consulting (Financial Media and IR)\n \n \n Simon Conway / Alex Shaw\n / George Kendrick\n \n \n \n \n \n \n \n Tel: +44(0) 203 727 1000\n \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Zyme Communications\n \n (Trade and Regional Media)\n \n \n Lily Jeffery\...